GSK press releases Follow https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-marketing-authorisation-for-rukobia-fostemsavir-a-first-in-class-attachment-inhibitor-in-combination-with-other-antiretrovirals/ gsk.com
